Altamira Therapeutics Ltd (fra:2QA) Share Price

Company Profile

Business description
Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy, viral infections, and inner ear disorders. Its product Bentrio, is a drug-free nasal spray for personal protection against airborne viruses and allergens. The company's OligoPhore / SemaPhore platform is a versatile system that allows the complexation of therapeutic RNAs with a proprietary peptide to form a nanoparticle formulation. This formulation allows for the delivery of therapeutic RNA by systemic administration to tissues affected by leaky vasculature, a hallmark of solid tumors and certain inflammatory conditions.
Contact
2 Church Street
Clarendon House
HamiltonHM11
BMU
T: +1 441 295-5950
E: [email protected]
https://www.altamiratherapeutics.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
13

Recommended

Investors will get to see if the new strategy and capital management framework are working.

Brian Han | 27 January 2026

These undervalued stocks with economic moats have increased their dividends for 25 consecutive years or more.

Susan Dziubinski | 27 January 2026

Central bankers are likely to hold interest rates steady, but Wall Street is focused on life after Powell.

Sarah Hansen | 26 January 2026

Index	Last price	Change	% Change
All Ordinaries	9,250.60	50.70	-0.55%
CAC 40	8,059.79	93.03	-1.14%
DAX 40	24,803.68	90.76	-0.36%
Dow JONES (US)	49,003.41	408.99	-0.83%
FTSE 100	10,159.40	48.40	-0.47%
HKSE	27,826.91	699.96	2.58%
NASDAQ	23,817.10	215.74	0.91%
Nikkei 225	53,358.71	25.17	0.05%
NZX 50 Index	13,412.87	98.01	-0.73%
S&P 500	6,978.60	28.37	0.41%
S&P/ASX 200	8,933.90	40.40	-0.45%
SSE Composite Index	4,151.24	11.33	0.27%